Short Summary
Samsung successfully convinced the PTAB to institute an IPR against Wilus Institute, challenging 16 wireless communication claims based on obviousness over prior art references like Lee.
Detailed Summary
The Patent Trial and Appeal Board granted institution of Inter Partes Review (IPR2025-00936) for Samsung Electronics Co., Ltd. against Wilus Institute of Standards and Technology Inc. The IPR challenges 16 claims related to wireless communication terminals, primarily asserting obviousness over prior art references Lee and Choudhury. The Board found Petitioner's arguments persuasive regarding Claim 1, noting that the 'coloring disable bit' in Lee functions as signaling information indicating an operation based on BSS color is not allowed, thereby meeting the threshold for institution.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Samsung Electronics Co., Ltd. et al. vs Wilus Institute of Standards and Technology Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
CISCO SYSTEMS, INC. et al.vsInfoExpress Inc.
CISCO SYSTEMS, INC. filed an IPR petition challenging claims of InfoExpress Inc.'s patent (8,347,350), arguing they are obvious under 35 U.S.C. § 103. The challenge relies on combining prior art references Krantz and Herrmann to demonstrate predictable network access control features.
Amazon.com, Inc. et al.vsKAIFI LLC
Amazon has filed an IPR petition seeking to invalidate KAIFI’s ’232 patent covering ubiquitous sensor‑network middleware, arguing that the claims are obvious over earlier publications by Jakobson and Tsetsos. The petition also disputes any discretionary denial, requesting the Board to institute the review.
Apple Inc.vsTelcom Ventures LLC
Apple has filed an IPR petition seeking cancellation of all 14 claims of Telcom Ventures’ ’743 patent, asserting that the claims are obvious over a combination of prior‑art references covering NFC‑based mobile payments.
Taiwan Semiconductor Manufacturing Company, Ltd. et al.vsMarlin Semiconductor Ltd. et al.
TSMC and Apple attempted to overturn USPTO denials of institution for Marlin Semiconductor patents, but the Board denied their Director Review requests, leaving the institution decisions intact.
Amgen Inc. et al.vsBristol-Myers Squibb Company
Amgen petitions the PTAB to invalidate Bristol‑Myers Squibb’s 10,174,113 melanoma immunotherapy patent, arguing the claims are obvious over public clinical‑trial data and lack written‑description support for the 480 mg dose.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.